Related Experiment Video
Updated: Jun 27, 2026
08:21
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Atheromatous renovascular disease: overview and challenges
Constantina Chrysochou1, Philip A Kalra
1Renal Department, Salford Royal Hospitals NHS Foundation Trust, Stott Lane, Salford, Manchester, UK. tinachrysochou@yahoo.co.uk
Journal of Renal Care
|December 19, 2008
Summary
Atheromatous renovascular disease (ARVD) is a common condition linked to kidney disease and hypertension. This review covers current challenges in diagnosing and treating ARVD.
Area of Science:
- Nephrology
- Cardiology
- Vascular Medicine
Background:
- Atheromatous renovascular disease (ARVD) is a prevalent and complex condition.
- ARVD is increasingly linked to chronic kidney disease (CKD), end-stage renal disease (ESRD), hypertension, and cardiovascular complications.
- Current diagnostic and treatment strategies for ARVD remain subjects of debate.
Purpose of the Study:
- To provide a comprehensive overview of Atheromatous renovascular disease (ARVD).
- To discuss the ongoing challenges and controversies in the investigation and management of ARVD.
Main Methods:
- Literature review of Atheromatous renovascular disease (ARVD).
- Synthesis of current evidence regarding diagnostic methods and treatment options.
- Identification of remaining challenges in the field.
Main Results:
- ARVD is a significant contributor to CKD and ESRD.
- The association between ARVD, hypertension, and cardiovascular burden is substantial.
- Uncertainty persists regarding optimal investigative and therapeutic approaches.
Conclusions:
- Further research is needed to clarify the safest investigative methods for ARVD.
- Optimizing treatment strategies for ARVD is crucial to improve patient outcomes.
- Addressing the complexities of ARVD is essential for managing associated comorbidities.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:06Renal Drug Clearance: Overview
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...